Bionomics (Nasdaq: BNOX, ASX:BNO) is a clinical-stage biopharmaceutical developing novel, allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system disorders with high unmet medical need. Bionomics is advancing its lead product candidate, BNC210, an oral, proprietary, selective negative allosteric modulator of the α7 nicotinic acetylcholine receptor, for the acute treatment of Social Anxiety Disorder and chronic treatment of Post-Traumatic Stress Disorder. Beyond BNC210, Bionomics has a strategic partnership with Merck & Co., Inc. (known as MSD outside the United States and Canada) with two drugs in early-stage clinical trials for the treatment of cognitive deficits in Alzheimer's disease and other central nervous system conditions. To learn more about the company, pipeline and collaboration opportunities, visit us at www.bionomics.com.au.
View Top Employees from Bionomics LtdWebsite | http://www.bionomics.com.au |
Ticker | BNO |
Revenue | $9 million |
Employees | 28 (22 on RocketReach) |
Founded | 1999 |
Address | 200 Greenhill Rd, Eastwood, South Australia 5063, AU |
Phone | +61 8 8354 6100 |
Fax | +61 8 8354 6199 |
Technologies |
JavaScript,
HTML,
Twitter
+22 more
(view full list)
|
Industry | Biotechnology Research, Pharmaceuticals, Biotechnology, Other Healthcare Services, Biopharmaceutical, Healthcare, Science and Engineering, Other Pharmaceuticals and Biotechnology, Cancer, Health Diagnostics, Central Nervous System Disorders, Health Care, Medical |
Web Rank | 14 Million |
Keywords | Mk-8719, Errol De Souza Bionomics, Synthetic Bionomics, Bionomics, Bno Assx |
Competitors | AGY Therapeutics, Inc., Boston Life Sciences Inc, Newron Pharmaceuticals SpA, Rexahn Pharmaceuticals, Xenon Pharmaceuticals Inc. |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies |
Looking for a particular Bionomics Ltd employee's phone or email?
The Bionomics Ltd annual revenue was $9 million in 2024.
Liz Doolin is the Vice President Clinical Development of Bionomics Ltd.
22 people are employed at Bionomics Ltd.
Bionomics Ltd is based in Eastwood, South Australia.
The NAICS codes for Bionomics Ltd are [3254, 325, 32541, 32].
The SIC codes for Bionomics Ltd are [28, 283].